Functional piglet model for the clinical syndrome and postmortem findings induced by staphylococcal enterotoxin B

Experimental Biology and Medicine

Volumn 229, Issue 10, 2004, Pages 1061-1071

  Van Gessel, Yvonne A ^a   Mani, Sachin ^a   Bi, Shuguang ^a   Hammamieh, Rasha ^a   Shupp, Jeffrey W ^a   Das, Rina ^a   Coleman, Gary D ^a   Jett, Marti ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

End organ failure; Hypoxia; Irreversible shock; Mesenteric edema; Pigs; Staphylococcal enterotoxin B; Superantigens; Toxic shock syndrome; Vascular collapse

Indexed keywords

MESSENGER RNA; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CADAVER; CELL AGGREGATION; CIRCULATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE SEVERITY; EDEMA; EXPOSURE; FEMALE; FEVER; HEPATITIS; HISTOLOGY; HYPOTENSION; INTOXICATION; LETHALITY; LUNG; LYMPHADENOPATHY; LYMPHATIC SYSTEM DISEASE; LYMPHOBLAST; LYMPHOCYTE; MALE; MESENTERY; MOLECULE; NONHUMAN; OBSERVATION; PEYER PATCH; RETROPERITONEUM; SPLENOMEGALY; SWINE; TOXIC SHOCK SYNDROME; VOMITING;

ANIMALIA; POSIBACTERIA; PRIMATES; RODENTIA; STAPHYLOCOCCUS; SUS SCROFA;

EID: 7244254172     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422901011     Document Type: Article

References (37)

1. Jett M, Brinkley W, Neill R, Gemski P, Hunt R. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun 58:3494-3499, 1990.
2. Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, Etienne J, Vandenesch F, Bonneville M, Lina G. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166:669-677, 2001.
3. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [erratum, Science 248:1066, 1990]. Science 248:705-711, 1990.
4. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer P, Wagner H. T-cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175:91-98, 1992.
5. Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 212:99-109, 1996.
6. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711-718, 1994.
7. Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin microbial superantigens. Faseb J 5:2706-2712, 1991.
8. Hamad AR, Marrack P, Kappler JW. Transcytosis of staphylococcal superantigen toxins. J Exp Med 185:1447-1454, 1997.
9. Shupp JW, Jett M, Pontzer CH. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect Immun 70:2178-2186, 2002.
10. McKay DM, Singh PK. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J Immunol 159:2382-2390, 1997.
11. Chatterjee S, Khullar M, Shi WY. Digalactosylceramide is the receptor for staphylococcal enterotoxin-B in human kidney proximal tubular cells. Glycobiology 5:327-333, 1995.
12. Chatterjee S, Jett M. Glycosphingolipids: the putative receptor for Staphylococcus aureus enterotoxin-B in human kidney proximal tubular cells. Mol Cell Biochem 113:25-31, 1992.
13. Normann SJ. Renal fate of staphylococcal enterotoxin B. Lab Invest 25:126-132, 1971.
14. Campbell WN, Fitzpatrick M, Ding X, Jett M, Gemski P, Goldblum SE. SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro. Am J Physiol 273:L31-L39, 1997.
15. Normann SJ, Jaeger RF, Johnsey RT. Pathology of experimental enterotoxemia. The in vivo localization of staphylococcal enterotoxin B. Lab Invest 20:17-25, 1969.
16. Stiles JW, Denniston JC. Response of the rhesus monkey, Macaca mulatta, to continuously infused staphylococcal enterotoxin B. Lab Invest 25:617-625, 1971.
17. Ulrich RG, Sidell S, Taylor TJ, Wilhelmsen CL, Franz DR. Staphylococcal enterotoxin B and related pyrogenic toxins. In: Sidell FR, Takafuji ET, Franz DR, eds. Textbook of Military Medicine. Part I: Warfare, Weaponry , and the Casualty. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, pp621-630, 1997.
18. Savransky V, Rostapshov V, Pinelis D, Polotsky Y, Korolev S, Komisar J, Fegeding K. Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol Pathol 31:373-378, 2003.
19. Anderson MR, Tary-Lehmann M. Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin Immunol 98:85-94, 2001.
20. Yeung RS, Penninger JM, Kundig T, Khoo W, Ohashi PS, Kroemer G, Mak TW. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol 26:1074-1082, 1996.
21. Chen JY, Qiao Y, Komisar JL, Baze WB, Hsu IC, Tseng J. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun 62:4626-4631, 1994.
22. Schantz EJ, Roessler WG, Wagman J, Spero L, Dunnery DA, Bergdoll MS. Purification of staphylococcal enterotoxin B. Biochemistry 4:1011-1016, 1965.
23. Feletou M, Teisseire B. Vascular pharmacology of the micropig: importance of the endothelium. In: Swindle MM, Moody DC, Phillips LD, Eds. Swine As Models in Biomedical Research. Ames: Iowa State University Press, pp74-95, 1992.
24. Lee PK, Vercellotti GM, Deringer JR, Schlievert PM. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J Infect Dis 164:711-719, 1991.
25. Hoban LD, Paschall JA, Eckstein J, Nadkari V, Lee CR, Williams TJ, Reusch D, Nevola JJ, Carcillo JA. Awake porcine model of intraperitoneal sepsis. In: Swindle MM, Moody DC, Phillips LD, Eds. Swine As Models in Biomedical Research. Ames: Iowa State University Press, pp246-264, 1992.
26. Finegold MJ. Interstitial pulmonary edema. An electron microscopic study of the pathology of staphylococcal enterotoxemia in Rhesus monkeys. Lab Invest 16:912-924, 1967.
27. Larkin SM, Williams DN, Osterholm MT, Tofte RW, Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann Intern Med 96:858-864, 1982.
28. Gelberg HB. Alimentary system. In: McGavin MD, Carltom WW, Zachary JF, Eds. Thomson's Special Veterinary Pathology (3rd ed.). St. Louis: Mosby, pp42-43, 2001.
29. Pang VF, Lorenzana RM, Beasley VR, Buck WB, Haschek WM. Experimental T-2 toxicosis in swine. III. Morphologic changes following intravascular administration of T-2 toxin. Fundam Appl Toxicol 8:298-309, 1987.
30. Landsverk T. Immune system. In: Dellmann D, Eurell JA, Eds. Textbook of Veterinary Histology (5th ed.). Baltimore: Williams & Wilkins, pp137-142, 1998.
31. Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB. Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol 23:262-268, 1995.
32. Hoffman M, Tremaine M, Mansfield J, Betley M. Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect Immun 64:885-890, 1996.
33. Jin K, Mao XO, Eshoo MW, del Rio G, Rao R, Chen D, Simon RP, Greenberg DA. cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro. Neurochem Res 27:1105-1112, 2002.
34. Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 8:242-250, 2002.
35. Droin NM, Pinkoski MJ, Dejardin E, Green DR. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses. Mol Cell Biol 23:7638-7647, 2003.
36. Hagiwara H, Sugiura N, Wakita K, Hirose S. Purification and characterization of angiotensin-binding protein from porcine liver cytosolic fraction. Eur J Biochem 185:405-410, 1989.
37. Webb RC, Kiron MA, Rosenberg E, Soffer RL. Antiserum to angiotensin-binding protein inhibits vascular responses to angiotensin II. Am J Physiol 255:H1542-H1544, 1988.